Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Payables: 2024

Historic Payables for Pyxis Oncology (PYXS) over the last 1 years, with Dec 2024 value amounting to $4.9 million.

  • Pyxis Oncology's Payables rose 100.33% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.9 million, marking a year-over-year change of. This contributed to the annual value of $4.9 million for FY2024, which is N/A change from last year.
  • Pyxis Oncology's Payables amounted to $4.9 million in FY2024.
  • Pyxis Oncology's 5-year Payables high stood at $4.9 million for FY2024, and its period low was $4.9 million during FY2024.
  • In the last 1 years, Pyxis Oncology's Payables had a median value of $4.9 million in 2024 and averaged $4.9 million.